Insulet Corp
PODD340.290USD
-1.490-0.44%
Handelsschluss 09/15, 16:00（ET）Kurse um 15 Minuten verzögert
23.95BMarktkapitalisierung
101.45KGV TTM
mehr Informationen über Insulet Corp Unternehmen
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.
Unternehmensinformationen
BörsenkürzelPODD
Name des UnternehmensInsulet Corp
IPO-datumMay 15, 2007
CEOMs. Ashley Mcevoy
Anzahl der mitarbeiter3900
WertpapierartOrdinary Share
GeschäftsjahresendeMay 15
Addresse100 Nagog Park
StadtACTON
BörseNASDAQ Global Select Consolidated
LandUnited States of America
Postleitzahl01720-3440
Telefon19786007000
Websitehttps://www.omnipod.com
BörsenkürzelPODD
IPO-datumMay 15, 2007
CEOMs. Ashley Mcevoy
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+2.89%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-8.50%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-28.94%
Ms. Ashley Mcevoy
Ms. Ashley Mcevoy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
9.54K
+238500.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+17.43%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+17.01%
Ms. Laetitia Cousin
Ms. Laetitia Cousin
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
Senior Vice President - Regulatory Affairs, Quality Assurance and Compliance
3.58K
--
Mr. Prem Singh
Mr. Prem Singh
Senior Vice President - Global Operations
Senior Vice President - Global Operations
3.56K
-16.16%
Dr. Luciana Borio, M.D.
Dr. Luciana Borio, M.D.
Independent Director
Independent Director
3.09K
-13.48%
Mr. Timothy C. (Tim) Stonesifer
Mr. Timothy C. (Tim) Stonesifer
Independent Director
Independent Director
2.89K
+36.78%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Jessica Hopfield, Ph.D.
Dr. Jessica Hopfield, Ph.D.
Independent Director
Independent Director
27.70K
+2.89%
Mr. Michael R. Minogue
Mr. Michael R. Minogue
Independent Director
Independent Director
14.85K
-8.50%
Mr. Eric Benjamin
Mr. Eric Benjamin
Chief Operating Officer
Chief Operating Officer
10.47K
-28.94%
Ms. Ashley Mcevoy
Ms. Ashley Mcevoy
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
9.54K
+238500.00%
Ms. Elizabeth H. (Bess) Weatherman
Ms. Elizabeth H. (Bess) Weatherman
Independent Director
Independent Director
5.24K
+17.43%
Ms. Lauren Budden
Ms. Lauren Budden
Chief Accounting Officer, Group Vice President, Corporate Controller
Chief Accounting Officer, Group Vice President, Corporate Controller
5.22K
+17.01%
Umsatzaufteilung
Währung: USDAktualisiert: Sun, Jul 6
Währung: USDAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
U.S.Omnipod
401.70M
70.60%
International Omnipod
152.40M
26.78%
Drug Delivery
14.90M
2.62%
Nach RegionUSD
Name
Umsatz
Anteil
United States
416.60M
73.22%
All Other
152.40M
26.78%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
U.S.Omnipod
401.70M
70.60%
International Omnipod
152.40M
26.78%
Drug Delivery
14.90M
2.62%
Aktionärsstatistik
Aktualisiert: Tue, Aug 19
Aktualisiert: Tue, Aug 19
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.33%
Fidelity Management & Research Company LLC
9.74%
Capital Research Global Investors
6.73%
BlackRock Institutional Trust Company, N.A.
6.18%
State Street Global Advisors (US)
4.34%
Andere
60.68%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
12.33%
Fidelity Management & Research Company LLC
9.74%
Capital Research Global Investors
6.73%
BlackRock Institutional Trust Company, N.A.
6.18%
State Street Global Advisors (US)
4.34%
Andere
60.68%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
64.41%
Investment Advisor/Hedge Fund
23.56%
Hedge Fund
5.82%
Research Firm
2.96%
Pension Fund
2.19%
Sovereign Wealth Fund
1.59%
Bank and Trust
1.21%
Individual Investor
0.28%
Private Equity
0.09%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
1541
72.80M
103.47%
-3.81M
2025Q1
1569
72.82M
103.50%
-3.52M
2024Q4
1508
72.57M
103.34%
-4.94M
2024Q3
1436
73.14M
104.31%
-3.15M
2024Q2
1408
72.17M
103.04%
-3.02M
2024Q1
1350
71.60M
102.26%
-3.12M
2023Q4
1320
72.91M
104.42%
-1.52M
2023Q3
1254
72.05M
103.19%
-4.06M
2023Q2
1223
73.42M
105.35%
-3.44M
2023Q1
1206
74.71M
107.20%
-300.49K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
8.64M
12.28%
+178.96K
+2.12%
Mar 31, 2025
Fidelity Management & Research Company LLC
7.13M
10.13%
+45.85K
+0.65%
Mar 31, 2025
Capital Research Global Investors
6.08M
8.64%
-1.37M
-18.40%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
4.36M
6.2%
+115.38K
+2.72%
Mar 31, 2025
State Street Global Advisors (US)
3.02M
4.3%
+49.05K
+1.65%
Mar 31, 2025
Baillie Gifford & Co.
2.25M
3.2%
-104.93K
-4.45%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.87M
2.66%
+90.07K
+5.06%
Mar 31, 2025
ClearBridge Investments, LLC
1.48M
2.1%
+73.68K
+5.24%
Mar 31, 2025
American Century Investment Management, Inc.
1.15M
1.64%
+297.73K
+34.83%
Mar 31, 2025
Fidelity International
1.29M
1.83%
-146.07K
-10.21%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Sep 6
Aktualisiert: Sat, Sep 6
Name
Anteil
Inspire 500 ETF
0%
Invesco S&P 500 Revenue ETF
0%
Goldman Sachs Innovate Equity ETF
0%
Wahed FTSE USA Shariah ETF
0%
iShares ESG MSCI USA Leaders ETF
0%
VictoryShares US 500 Enhanced Volatility Wtd ETF
0%
Invesco S&P 500 Equal Weight Income Advantage ETF
0%
iShares MSCI USA Size Factor ETF
0%
iShares MSCI Global Sustainable Development Goals
0%
Invesco S&P 500 QVM Multi-factor ETF
0%
Mehr Anzeigen
Inspire 500 ETF
Anteil0%
Invesco S&P 500 Revenue ETF
Anteil0%
Goldman Sachs Innovate Equity ETF
Anteil0%
Wahed FTSE USA Shariah ETF
Anteil0%
iShares ESG MSCI USA Leaders ETF
Anteil0%
VictoryShares US 500 Enhanced Volatility Wtd ETF
Anteil0%
Invesco S&P 500 Equal Weight Income Advantage ETF
Anteil0%
iShares MSCI USA Size Factor ETF
Anteil0%
iShares MSCI Global Sustainable Development Goals
Anteil0%
Invesco S&P 500 QVM Multi-factor ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
